findmyKOL
Clinical trialNCT03466073CompletedPhase 1/PHASE2Interventional

A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP

SponsorBioAegis Therapeutics Inc.Enrollment33Community-acquired Pneumonia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Phase 1b/2a, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Plasma gelsolin (rhu-pGSN) Added to Standard of Care in Subjects Hospitalized for Acute Community-acquired Pneumonia (CAP)
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Cairns Hospital

    Cairns, Queensland, Australia

  • Box Hill Hospital

    Box Hill, Victoria, Australia

  • Footscray Hospital

    Footscray, Victoria, Australia

Georgia
  • Ltd Geo Hospitals, Mtskheta Multiprofile Medical Center

    Mtskheta, Georgia

  • Jsc Rustavi Central Hospital

    Rustavi, Georgia

  • Ltd 5th Clinical Hospital

    Tbilisi, Georgia

  • Ltd Central University Clinic After Academic N. Kipshidze

    Tbilisi, Georgia

  • Ltd S. Khechinashvili University Hospital

    Tbilisi, Georgia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Recombinant human plasma gelsolin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Aug 2018
Primary completion
2 Apr 2019
Completion
2 Apr 2019
Last update posted
27 Jan 2020
Registered enrollment
33
Registry id
NCT03466073
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.